Abstract

Cancer theranostics, which aims to integrate diagnostics and therapy for cancer treatment, has benefited greatly from recent advancements in nanomaterials. This study focuses on the most recent advancements in cancer theranostic techniques using quantum dots, silica nanoparticles, and carbon-based nanomaterials. Over the last decade, responsive nanocarriers made from these nanomaterials have shown promise in cancer-specific theranostics. Several experiments in cell and mouse models have suggested their underlying therapeutic efficacy; however, comprehensive and long-term in vivo clinical evaluations are undoubtedly expected to make these bench-made materials compatible in real-world settings.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call